Related Experiment Video
Updated: Jun 8, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney
Trine Madsen1, Jeppe H Christensen, My Svensson
1Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark. trine.madsen@rn.dk
Objective:
Patients with end-stage renal disease treated with chronic hemodialysis (HD) are reported to have low levels of marine n-3 polyunsaturated fatty acids (PUFA) in plasma and cell membranes compared with healthy subjects. The aim of this study was to investigate whether n-3 PUFA levels in plasma and cells are lower in HD patients as compared with subjects without kidney disease.
Research Design:
A comparative study was carried out.
Setting:
This study was carried out at the Departments of Nephrology and Cardiology, Aalborg Hospital, Aarhus University Hospital, Denmark.
Participants:
This study consisted of 2 study populations comprising HD patients and 5 study populations comprising subjects without kidney disease.
Intervention:
The fatty acid distribution in plasma phospholipids and platelet phospholipids was measured using gas chromatography.
Main Outcome Measure:
Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and arachidonic acid (AA) levels in plasma or serum phospholipids and platelet phospholipids in HD patients were compared with n-3 PUFA levels in subjects without kidney disease.
Results:
EPA and DHA were lower and AA/EPA was higher in plasma/serum phospholipids in HD patients than in subjects without kidney disease. Similarly, higher AA and AA/EPA and lower EPA and DHA levels were found in platelet phospholipids of HD patients. Adjustment for gender, age, and habitual intake of fish and fish oil supplements did not change these results.
Conclusion:
HD patients have lower n-3 PUFA levels in plasma and cells compared with subjects without kidney disease.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Atherosclerosis III: Management
Heart Failure VI: Adjunct Therapies
Kidney Transplant III: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
